The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin.
Open accessAbstract
We have identified 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin ([3H]7-OH-DPAT) as a selective probe for the recently cloned dopamine D3 receptor and used it to assess the presence of this receptor and establish its distribution and properties in brain. In transfected Chinese hamster ovary (CHO) cells, it binds to D3 receptors with subnanomolar affinity, whereas its affinity is approximately 100-, 1000-, and 10,000-fold lower at D2, D4, and D1 receptors, respectively. Specific [3H]7-OH-DPAT binding sites, with a Kd of 0.8 nM and a pharmacology similar to those at reference D3 receptors of CHO cells, were identified in rat brain. D3 receptors differ from D2 receptors in brain by their lower abundance (2 orders of magnitude) and distribution, restricted to a few mainly phylogenetically ancient areas--e.g., paleostriatum and archicerebellum--as evidenced by membrane binding are autoradiography studies. Native D3 receptors in brain are characterized by an unusually high nanomolar affinity for dopamine and a low modulatory influence of guanyl nucleotides on agonist binding. These various features suggest that D3 receptors are involved in a peculiar mode of neurotransmission in a restricted subpopulation of dopamine neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L., & Schwartz, J.-C. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,609
Self-citationVan Tol, H. H. M., Bunzow, J. R., Guan, H.-C., Sunahara, R. K., Seeman, P., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,014
Swanson, L. W. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90145-9 · Cited by 1,718
Efferent connections of the substantia nigra and ventral tegmental area in the rat
Beckstead, R. M., Domesick, V. B., & Nauta, W. J. H. (1979) · Brain Research · doi:10.1016/0006-8993(79)91001-1 · Cited by 1,293
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1
Sunahara, R. K., Guan, H.-C., O'Dowd, B. F., Seeman, P., Laurier, L. G., Ng, G., George, S. R., Torchia, J., Van Tol, H. H. M., & Niznik, H. B. (1991) · Nature · doi:10.1038/350614a0 · Cited by 1,165
Cloning and expression of a rat D2 dopamine receptor cDNA
Bunzow, J. R., Tol, H. H. M. V., Grandy, D. K., Albert, P., Salon, J., Christie, M., Machida, C. A., Neve, K. A., & Civelli, O. (1988) · Nature · doi:10.1038/336783a0 · Cited by 1,117
Bouthenet, M.-L., Souil, E., Martres, M.-P., Sokoloff, P., Giros, B., & Schwartz, J.-C. (1991) · Brain Research · doi:10.1016/0006-8993(91)91456-b · Cited by 868
Self-citationMolecular cloning and expression of the gene for a human D1 dopamine receptor
Dearry, A., Gingrich, J. A., Falardeau, P., Fremeau, R. T., Bates, M. D., & Caron, M. G. (1990) · Nature · doi:10.1038/347072a0 · Cited by 674
Zetterström, T., Sharp, T., Marsden, C. A., & Ungerstedt, U. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00893.x · Cited by 616
Cited by
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Schotte, A., Janssen, P. F. M., Gommeren, W., Luyten, W. H. M. L., Van Gompel, P., Lesage, A. S., De Loore, K., & Leysen, J. E. (1996) · Psychopharmacology · doi:10.1007/bf02245606 · Cited by 1,167
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
Baik, J.-H., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., Le Meur, M., & Borrelli, E. (1995) · Nature · doi:10.1038/377424a0 · Cited by 650
Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Spanagel, R. (2009) · Physiological Reviews · doi:10.1152/physrev.00013.2008 · Cited by 634
Dopamine: a potential substrate for synaptic plasticity and memory mechanisms
Jay, T. M. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00085-6 · Cited by 577
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist
Pilla, M., Perachon, S., Sautel, F., Garrido, F., Mann, A., Wermuth, C. G., Schwartz, J.-C., Everitt, B. J., & Sokoloff, P. (1999) · Nature · doi:10.1038/22560 · Cited by 565
Self-citationPathophysiology of levodopa-induced dyskinesia: Potential for new therapies
Bezard, E., Brotchie, J. M., & Gross, C. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086062 · Cited by 503
Opposite Modulation of Cocaine-Seeking Behavior by D 1 - and D 2 -Like Dopamine Receptor Agonists
Self, D. W., Barnhart, W. J., Lehman, D. A., & Nestler, E. J. (1996) · Science · doi:10.1126/science.271.5255.1586 · Cited by 492
Logue, S. F., & Gould, T. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.007 · Cited by 477
Dopamine receptors: Molecular biology, biochemistry and behavioural aspects
Jackson, D. M., & Westlind-Danielsson, A. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90041-8 · Cited by 483
Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground
Weinberger, D. R., & Lipska, B. K. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)00013-c · Cited by 470
Modulation of Cocaine Self-Administration in the Rat Through D-3 Dopamine Receptors
Caine, S. B., & Koob, G. F. (1993) · Science · doi:10.1126/science.8099761 · Cited by 454
Mesocortical dopamine modulation of executive functions: beyond working memory
Floresco, S. B., & Magyar, O. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0404-5 · Cited by 426
Genetics of dopamine receptors and drug addiction: a comprehensive review
Foll, B. L., Gallo, A., Strat, Y. L., Lu, L., & Gorwood, P. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283242f05 · Cited by 393
The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance
Levant, B. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01327-9 · Cited by 385
Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain
Diaz, J., Lévesque, D., Lammers, C. H., Griffon, N., Martres, M.-P., Schwartz, J.-C., & Sokoloff, P. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00527-c · Cited by 352
Self-citationInduction of dopamine D 3 receptor expression as a mechanism of behavioral sensitization to levodopa
Bordet, R., Ridray, S., Carboni, S., Diaz, J., Sokoloff, P., & Schwartz, J.-C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3363 · Cited by 345
Self-citationPiggott, M. A., Marshall, E. F., Thomas, N., Lloyd, S., Court, J. A., Jaros, E., Burn, D., Johnson, M., Perry, R. H., McKeith, I. G., et al. (1999) · Brain · doi:10.1093/brain/122.8.1449 · Cited by 330
Comparative postnatal development of dopamine D1, D2 and D4 receptors in rat forebrain
Tarazi, F. I., & Baldessarini, R. J. (2000) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(99)00108-2 · Cited by 327
Dopamine D3Receptors Expressed by All Mesencephalic Dopamine Neurons
Diaz, J., Pilon, C., Le Foll, B., Gros, C., Triller, A., Schwartz, J.-C., & Sokoloff, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08677.2000 · Cited by 326
Self-citationMurray, A. M., Ryoo, H. L., Gurevich, E., & Joyce, J. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11271 · Cited by 325
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence
Heidbreder, C. A., Gardner, E. L., Xi, Z.-X., Thanos, P. K., Mugnaini, M., Hagan, J. J., & Ashby, C. R. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.033 · Cited by 322
Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
Mailman, R., & Murthy, V. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361461 · Cited by 311
Adaptive Increase in D3Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities
Staley, J. K., & Mash, D. C. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06100.1996 · Cited by 308
Augmentation of drug reward by chronic food restriction
Carr, K. D. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00759-x · Cited by 300
Kourounakis, A. P., Xanthopoulos, D., & Tzara, A. (2020) · Medicinal Research Reviews · doi:10.1002/med.21634 · Cited by 294
Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors
Mierau, J., Schneider, F. J., Ensinger, H. A., Chio, C. L., Lajiness, M. E., & Huff, R. M. (1995) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(95)90013-6 · Cited by 257
The dopamine D3-receptor: A postsynaptic receptor inhibitory on rat locomotor activity
Waters, N., Svensson, K., Haadsma-Svensson, S. R., Smith, M. W., & Carlsson, A. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244979 · Cited by 255
Opponent Process Model and Psychostimulant Addiction
Koob, G. F., Caine, S. B., Parsons, L., Markou, A., & Weiss, F. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00438-8 · Cited by 196
Variability in D2‐dopamine receptor density and affinity: A PET study with [11C]raclopride in man
Farde, L., Hall, H., Pauli, S., & Halldin, C. (1995) · Synapse · doi:10.1002/syn.890200303 · Cited by 175
Bachtell, R. K., Whisler, K., Karanian, D., & Self, D. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0133-1 · Cited by 154
“We compared the ability of intra-NAc infusions of the D1-selective agonist SKF 81297 (>500-fold D1/D2; Andersen and Jansen 1990) and the D2-selective agonist 7-OH-DPAT (>1,000-fold D2–3/D1; Levesque et al. 1992; Gonzalez and Sibley 1995; Levant et al. 1996) to reinstate cocaine-seeking behavior.”
BackgroundCourt, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135
Barrus, M. M., & Winstanley, C. A. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2225-15.2016 · Cited by 93
“Whereas the D2 receptor is expressed fairly ubiquitously in sites innervated by dopamine, the D3 receptor is concentrated within the nucleus accumbens (NAc), islands of Calleja, and limbic structures such as the hippocampus and amygdala (Bouthenet et al., 1991, Lévesque et al., 1992).”
BackgroundThe dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset
Smith, A. G., Neill, J. C., & Costall, B. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00230-5 · Cited by 71
Papp, M., Gruca, P., Lason-Tyburkiewicz, M., Litwa, E., Niemczyk, M., Tota-Glowczyk, K., & Willner, P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4651-4 · Cited by 40
Metadata
- Authors
- Lévesque, D., Diaz, J., Pilon, C., Martres, M. P., Giros, B., Souil, E., Schott, D., Morgat, J. L., Schwartz, J. C., & Sokoloff, P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-09
- Volume
- 89
- Issue
- 17
- Pages
- 8155-8159
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2048937194
- Cited by
- 674
- References
- 23
- FWCI
- 16.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.